Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

Clinical trial NCT02262676 · COMPLETED

Trial details

NCT number: NCT02262676
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation

Start date: 2014-10-01
Primary completion: 2015-02-01
Enrollment: 2251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.